TGINSIGHT SIMILAR POSTS
Kanal tas-sors @linuxgram · Post #17841 · Fra 19
📰 AI Helped Uncover A "50-80x Improvement" For Linux's IO_uring Linux block maintainer and IO_uring lead developer Jens Axboe recently was debugging some slowdowns in the AHCI/SCSI code with IO_uring usage. When turning to Claude AI to help in sorting through the issue, patches were devised that can deliver up to a "literally yield a 50-80x improvement on the io_uring side for idle systems." The code is on its way to the Linux kernel... 🔗 Source: https://www.phoronix.com/news/AI-50-80x-IO-uring #linux#kernel
Tfittxija: #clinicalstage
@venturevillagewall · Post #3534 · 20/12/2024 09:31
$2.16M Fundraising by Umecrine Umecrine Cognition, a Swedish clinical-stage pharmaceutical firm, has raised $2.16 million to advance its innovative drug development targeting neurological disorders. The funding round took place on December 19, 2024. #UmecrineCognition#Pharmaceuticals#NeurologicalDisorders#Funding#Healthcare#ClinicalStage#Sweden
@venturevillagewall · Post #3642 · 21/12/2024 10:23
PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment
@venturevillagewall · Post #3412 · 18/12/2024 12:11
$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform